BlackRock Group’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.53M | Buy |
91,698
+4,883
| +6% | +$81.4K | ﹤0.01% | 1919 |
|
|
2016
Q3 | $1.79M | Buy |
86,815
+13,567
| +19% | +$279K | ﹤0.01% | 1686 |
|
|
2016
Q2 | $2.24M | Sell |
73,248
-212
| -0.3% | -$6.49K | ﹤0.01% | 1485 |
|
|
2016
Q1 | $2.75M | Buy |
73,460
+27,868
| +61% | +$1.04M | ﹤0.01% | 1345 |
|
|
2015
Q4 | $1.97M | Sell |
45,592
-1,307
| -3% | -$56.4K | ﹤0.01% | 1482 |
|
|
2015
Q3 | $1.76M | Buy |
46,899
+7,999
| +21% | +$300K | ﹤0.01% | 1565 |
|
|
2015
Q2 | $1.32M | Sell |
38,900
-8,683
| -18% | -$295K | ﹤0.01% | 1780 |
|
|
2015
Q1 | $1.69M | Sell |
47,583
-662
| -1% | -$23.4K | ﹤0.01% | 1555 |
|
|
2014
Q4 | $1.64M | Buy |
48,245
+4,619
| +11% | +$157K | ﹤0.01% | 1582 |
|
|
2014
Q3 | $1.68M | Sell |
43,626
-15,755
| -27% | -$607K | ﹤0.01% | 1487 |
|
|
2014
Q2 | $2.31M | Sell |
59,381
-221,273
| -79% | -$8.61M | ﹤0.01% | 1377 |
|
|
2014
Q1 | $9.6M | Buy |
280,654
+43,154
| +18% | +$1.48M | 0.01% | 919 |
|
|
2013
Q4 | $4.98M | Buy |
237,500
+6,223
| +3% | +$131K | ﹤0.01% | 1069 |
|
|
2013
Q3 | $5.43M | Buy |
231,277
+57,836
| +33% | +$1.36M | ﹤0.01% | 1032 |
|
|
2013
Q2 | $4.66M | Buy |
+173,441
| New | +$4.66M | ﹤0.01% | 1007 |
|